Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in DPN or PHN
NCT00629681Phase 4Completed
- Sponsor
- Viatris
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pregabalin in diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN), sponsored by Viatris. Primary endpoint: Correlation between Clinical Global Impression of Change and Patient Global Impression of Change and changes in pain, anxiety, and sleep parameters at 4 weeks. Started Nov 2004; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00629681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629681.